Session information

Diabetes update and pharmacology

Learning Outcomes:

1. Identify the cardio-renal-metabolic (CRM) implications of T2D​
2. Identify the changing treatment  paradigm of comprehensive risk management  of T2D  ​
3. Identify when and which therapies to use after Metformin in line with new evidence​
4. Identify how to align clinical practice guidelines to PBS reimbursement

 

Back to conference program